raloxifene hydrochloride has been researched along with cholecalciferol in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 13 (68.42) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Confavreux, E; Draper, MW; Garnero, P; Liu, T; Liu-Leage, S; Meunier, PJ; Paris, E; Sarkar, S; Vignot, E; Wong, M | 1 |
| Black, D; Cox, D; Cummings, S; Duong, T; Lips, P; Nickelsen, T; Oleksik, A | 1 |
| Pfeilschifter, J | 1 |
| Hayashi, Y | 1 |
| Boivin, G; Harper, KD; Lips, P; Meunier, PJ; Ott, SM; Pinette, KV; Sarkar, S | 1 |
| Calcagnile, F; Carlo Isaia, G; Cosentino, L; D'Amelio, P; Muratore, M; Quarta, E; Tamone, C; Tinelli, F | 1 |
| Center, JR; Eisman, JA; Nguyen, TV | 1 |
| Brixen, K; Mosekilde, L; Vestergaard, P | 1 |
| Bistrović, D; Cosić, V; Herman, D; Miskić, B; Miskić, D; Vizner, B | 1 |
| Inoue, D | 1 |
| Nakamura, T | 1 |
| Soen, S | 1 |
| Hagino, H | 1 |
| Ohashi, S; Ono, K; Tanaka, S | 1 |
| Hamaya, E; Ohta, H; Sowa, H; Taketsuna, M | 1 |
| Kosiorowska, J; Szymańska-Chabowska, A; Tański, W | 1 |
| Cho, K; Gwon, MR; Jung, W; Kang, WY; Lee, B; Lee, HW; Seong, SJ; Yoon, YR | 1 |
| Chung, YS; Lee, DY | 1 |
9 review(s) available for raloxifene hydrochloride and cholecalciferol
| Article | Year |
|---|---|
[Advancement of treatment for osteoporosis].
Topics: Alendronate; Bone Density; Cholecalciferol; Clinical Trials as Topic; Estrogen Replacement Therapy; Etidronic Acid; Fractures, Bone; Humans; Hydroxycholecalciferols; Osteoporosis; Raloxifene Hydrochloride; Vitamin K 2 | 2002 |
Osteoporosis: underrated, underdiagnosed and undertreated.
Topics: Aged; Bone Density; Calcium, Dietary; Cholecalciferol; Diagnostic Errors; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Spontaneous; Humans; Male; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Treatment Failure | 2004 |
[Treatment of osteoporosis with antiresorptive drugs].
Topics: Bone Density; Bone Resorption; Calcitonin; Calcium; Cholecalciferol; Diphosphonates; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D | 2005 |
[Current and future prospects for anti-osteoporotic drugs].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cholecalciferol; Clinical Trials as Topic; Denosumab; Diphosphonates; Drug Administration Schedule; Drug Design; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Patient Compliance; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Thiophenes | 2007 |
[Adverse events of drugs for the treatment of osteoporosis].
Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Cholecalciferol; Diphosphonates; Gastrointestinal Diseases; Hot Flashes; Humans; Hypercalcemia; Jaw Diseases; Macular Edema; Necrosis; Osteoporosis; Raloxifene Hydrochloride; Venous Thrombosis | 2007 |
[First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Cholecalciferol; Diphosphonates; Evidence-Based Medicine; Femoral Neck Fractures; Humans; Meta-Analysis as Topic; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures | 2007 |
[Combination therapy for osteoporosis].
Topics: Alendronate; Bone Density Conservation Agents; Calcitonin; Calcium; Cholecalciferol; Diphosphonates; Drug Therapy, Combination; Humans; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin K 2 | 2007 |
[Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cholecalciferol; Denosumab; Diphosphonates; Drug Therapy, Combination; Fractures, Spontaneous; Humans; Ibandronic Acid; Molecular Targeted Therapy; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures; Teriparatide | 2014 |
Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment.
Topics: Cholecalciferol; Denosumab; Dietary Supplements; Diphosphonates; Exercise; Humans; Kinesiology, Applied; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Teriparatide; Thiophenes | 2021 |
6 trial(s) available for raloxifene hydrochloride and cholecalciferol
| Article | Year |
|---|---|
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
Topics: Aged; Biomarkers; Bone Density; Bone Remodeling; Calcium; Cholecalciferol; Cholesterol; Cholesterol, LDL; Double-Blind Method; Estrogen Antagonists; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 1999 |
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Bone Density; Calcifediol; Calcium; Cholecalciferol; Female; Humans; Immunoradiometric Assay; Middle Aged; Nutritional Status; Osteoporosis, Postmenopausal; Parathyroid Hormone; Postmenopause; Radioimmunoassay; Raloxifene Hydrochloride; Seasons | 2001 |
Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women.
Topics: Aged; Calcification, Physiologic; Calcium, Dietary; Cholecalciferol; Densitometry; Dietary Supplements; Double-Blind Method; Female; Humans; Ilium; Microradiography; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Cholecalciferol; Clodronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
Effects of raloxifene on changes in bone density.
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Cholecalciferol; Female; Humans; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2006 |
Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.
Topics: Adult; Cholecalciferol; Cross-Over Studies; Drug Interactions; Healthy Volunteers; Humans; Male; Raloxifene Hydrochloride | 2022 |
4 other study(ies) available for raloxifene hydrochloride and cholecalciferol
| Article | Year |
|---|---|
[Risk-adapted therapy of osteoporosis. Preventing fractures].
Topics: Absorptiometry, Photon; Aged; Calcium, Dietary; Cholecalciferol; Diphosphonates; Exercise; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment | 2001 |
[Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
Topics: Age Factors; Aged; Alendronate; Calcium; Cholecalciferol; Diphosphonates; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sex Factors | 2003 |
Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study.
Topics: Aged; Bone Density Conservation Agents; Cholecalciferol; Drug Therapy, Combination; Female; Humans; Japan; Middle Aged; Osteoporosis, Postmenopausal; Pain; Pain Measurement; Product Surveillance, Postmarketing; Prospective Studies; Quality of Life; Raloxifene Hydrochloride; Surveys and Questionnaires | 2015 |
Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women.
Topics: Aged; Cholecalciferol; Female; Humans; Male; Middle Aged; Osteoporosis, Postmenopausal; Patient Satisfaction; Postmenopause; Prospective Studies; Quality of Life; Raloxifene Hydrochloride | 2022 |